Based on the assessment criteria, the expression rates of p53 and PD-L1 within DLBCL tissues were 44.9% (79/176) and 42.0% (74/176), respectively, yielding a co-expression of 25.6% (45/176), as illustrated in Table 2. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.